Literature DB >> 18579586

Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase Lyn.

Mark Rovedo1, Richard Longnecker.   

Abstract

Latent membrane protein 2A (LMP2A) is a viral protein expressed during Epstein-Barr virus (EBV) latency in EBV-infected B cells both in cell culture and in vivo. LMP2A has important roles in modulating B-cell receptor signal transduction and provides survival and developmental signals to B cells in vivo. Although Lyn has been shown to be important in mediating LMP2A signaling, it is still unclear if Lyn is used preferentially or if LMP2A associates promiscuously with other Src family kinase (SFK) members. To investigate the role of various SFKs in LMP2A signaling, we crossed LMP2A transgenic mice (TgE) with Lyn(-/-), Fyn(-/-), or Blk(-/-) mice. TgE Lyn(-/-) mice had a larger immunoglobulin M (IgM)-positive B-cell population than TgE mice, suggesting that the absence of Lyn prevents LMP2A from delivering survival and developmental signals to the B cells. Both TgE Fyn(-/-) and TgE Blk(-/-) mice have an IgM-negative population of splenic B cells, similar to the TgE mice. LMP2A was also transiently transfected into the human EBV-negative B-cell line BJAB to determine which SFK members associate with LMP2A. Lyn was detected in LMP2A immunoprecipitates, whereas Fyn was not. Both Lyn and Fyn were able to bind to an LMP2A mutant which contained a sequence shown previously to bind tightly to the SH2 domain of multiple SFK members. From these results, we conclude that LMP2A preferentially associates with and signals through Lyn compared to its association with other SFKs. This preferential association is due in part to the SH2 domain of Lyn associating with LMP2A.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579586      PMCID: PMC2519656          DOI: 10.1128/JVI.00843-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  97 in total

1.  An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases.

Authors:  A L Burkhardt; J B Bolen; E Kieff; R Longnecker
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

2.  SH2 domains recognize specific phosphopeptide sequences.

Authors:  Z Songyang; S E Shoelson; M Chaudhuri; G Gish; T Pawson; W G Haser; F King; T Roberts; S Ratnofsky; R J Lechleider
Journal:  Cell       Date:  1993-03-12       Impact factor: 41.582

3.  CD19 is a substrate of the antigen receptor-associated protein tyrosine kinase in human B cells.

Authors:  C M Roifman; S Ke
Journal:  Biochem Biophys Res Commun       Date:  1993-07-15       Impact factor: 3.575

4.  The CR2/CD19 complex on human B cells contains the src-family kinase Lyn.

Authors:  C J van Noesel; A C Lankester; G M van Schijndel; R A van Lier
Journal:  Int Immunol       Date:  1993-07       Impact factor: 4.823

5.  An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking.

Authors:  C L Miller; J H Lee; E Kieff; R Longnecker
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

6.  Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes.

Authors:  C L Miller; R Longnecker; E Kieff
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

7.  SH2 domains of the protein-tyrosine kinases Blk, Lyn, and Fyn(T) bind distinct sets of phosphoproteins from B lymphocytes.

Authors:  S N Malek; S Desiderio
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

8.  In vivo binding properties of SH2 domains from GTPase-activating protein and phosphatidylinositol 3-kinase.

Authors:  J A Cooper; A Kashishian
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

9.  Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav.

Authors:  Z Songyang; S E Shoelson; J McGlade; P Olivier; T Pawson; X R Bustelo; M Barbacid; H Sabe; H Hanafusa; T Yi
Journal:  Mol Cell Biol       Date:  1994-04       Impact factor: 4.272

10.  Tyrosine phosphorylation of CD19 in pre-B and mature B cells.

Authors:  N J Chalupny; S B Kanner; G L Schieven; S F Wee; L K Gilliland; A Aruffo; J A Ledbetter
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

View more
  16 in total

Review 1.  Viral proteins and Src family kinases: Mechanisms of pathogenicity from a "liaison dangereuse".

Authors:  Mario Angelo Pagano; Elena Tibaldi; Giorgio Palù; Anna Maria Brunati
Journal:  World J Virol       Date:  2013-05-12

2.  EBV-related lymphomas: new approaches to treatment.

Authors:  Jennifer A Kanakry; Richard F Ambinder
Journal:  Curr Treat Options Oncol       Date:  2013-06

3.  Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A.

Authors:  Jamie L Dargart; Kamonwan Fish; Leo I Gordon; Richard Longnecker; Osman Cen
Journal:  Antiviral Res       Date:  2012-05-16       Impact factor: 5.970

4.  Polymeric immunoglobulin receptor-mediated invasion of Streptococcus pneumoniae into host cells requires a coordinate signaling of SRC family of protein-tyrosine kinases, ERK, and c-Jun N-terminal kinase.

Authors:  Vaibhav Agarwal; Tauseef M Asmat; Nina I Dierdorf; Christof R Hauck; Sven Hammerschmidt
Journal:  J Biol Chem       Date:  2010-09-09       Impact factor: 5.157

5.  Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A.

Authors:  Kathryn T Bieging; Michelle Swanson-Mungerson; Alexandra C Amick; Richard Longnecker
Journal:  Cell Cycle       Date:  2010-03-03       Impact factor: 4.534

Review 6.  Cancers associated with human gammaherpesviruses.

Authors:  Kwun Wah Wen; Linlin Wang; Joshua R Menke; Blossom Damania
Journal:  FEBS J       Date:  2021-09-18       Impact factor: 5.622

7.  The c-Cbl proto-oncoprotein downregulates EBV LMP2A signaling.

Authors:  Masato Ikeda; Richard Longnecker
Journal:  Virology       Date:  2008-12-10       Impact factor: 3.616

Review 8.  Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.

Authors:  Zeina Al-Mansour; Beverly P Nelson; Andrew M Evens
Journal:  Curr Hematol Malig Rep       Date:  2013-09       Impact factor: 3.952

9.  EBV latent membrane protein 2A orchestrates p27kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice.

Authors:  Kamonwan Fish; Richard P Sora; Samantha J Schaller; Richard Longnecker; Masato Ikeda
Journal:  Blood       Date:  2017-10-26       Impact factor: 22.113

10.  Screening and functional analysis of differentially expressed genes in EBV-transformed lymphoblasts.

Authors:  Yongming Dai; Yunlian Tang; Fei He; Yang Zhang; Ailan Cheng; Runliang Gan; Yimou Wu
Journal:  Virol J       Date:  2012-03-30       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.